SECTM1 is upregulated in immuno-hot tumors and predicts immunotherapeutic efficacy in multiple cancers

Mostrar otras versiones (1)

Immune checkpoint inhibitors (ICIs) have transformed the management of advanced cancers. However, many patients could not benefit from ICIs therapy, and thus several biomarkers for therapeutic prediction have been uncovered. In this research, more than ten public and in-house cohorts were used to ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Jie, Fu, Ziyi, Cai, Yun, Song, Chenghu, Zhou, Jiaofeng, Zhu, Yichao, Mao, Wenjun, Xu, Junying, Yin, Yongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932126/
https://www.ncbi.nlm.nih.gov/pubmed/36818292
http://dx.doi.org/10.1016/j.isci.2023.106027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932126/
https://www.ncbi.nlm.nih.gov/pubmed/36818292
http://dx.doi.org/10.1016/j.isci.2023.106027

Ejemplares similares